Open House Drug Discount Agreements Brinzolamid and Brimonidin, ATC S01EC24
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Brinzolamid und Brimonidin, ATC S01EC24
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No guaranteed minimum volume or sales; agreements are non-exclusive and can be overridden by other discount contracts.
Strict submission rules: paper documents require two original copies, and electronic submissions require qualified elec...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Mar 2027
- Non-exclusive pharmaceutical rebate agreements for Brinzolamid and Brimonidin (ATC S01EC24)
- Agreements are identical and non-negotiable
Show full summary
This is an open-house model for non-exclusive rebate agreements for the active substances Brinzolamid and Brimonidin (ATC S01EC24) with AOK Bayern. It is not a standard procurement procedure; any qualified pharmaceutical company can enter into identical, non-negotiable agreements. The contract runs from April 1, 2025 to March 31, 2027, with possible entry anytime until February 5, 2027.
Risks
No guaranteed minimum volume or sales; agreements are non-exclusive and can be overridden by other discount contracts.
Strict submission rules: paper documents require two original copies, and electronic submissions require qualified elec...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Only pharmaceutical companies may participate
Administrative
- Submit signed self-declaration of reliability
- Submit signed contract and annex listing the specific drugs
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open House Drug Discount Agreements Brinzolamid and Brimonidin, ATC S01EC24
Non-exclusive rebate agreements for the specified active substances, open to all qualified pharmaceutical companies.
Location
Duration
Category
Award Criteria
Deadline
Award details
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich!
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Brinzolamid und Brimonidin, ATC S01EC24
Original TED description
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich!
Procurement Details
- Publication date
- 17 Feb 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 106957-2025
Documents (2)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No guaranteed minimum volume or sales; agreements are non-exclusive and can be overridden by other discount contracts.
Strict submission rules: paper documents require two original copies, and electronic submissions require qualified elec...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications